🔗 Permalink

Inventor profile of:

Kenya Shitara

City:

Machida-shi

Country:

Japan

Published Applications:

Last publication date:

2018-02-01

Top Assignees for applications by Kenya Shitara

The entities that hold a legal rights for patent applications filed by inventor Shitara Kenya:

KYOWA HAKKO KIRIN CO., LTD. 9 Tokyo, Japan
KYOWA HAKKO KIRIN CO., LTD. 2 Chiyoda-ku, Japan
KYOWA HAKKO KOGYO CO., LTD. 1 Tokyo, Japan
KYOWA KIRIN CO., LTD. 1 Tokyo, Japan
KYOWA HAKKO KOGYO CO., LTD. 1 Chiyoda-ku, Japan

Recent patent applications by Shitara Kenya

Kenya Shitara from Machida-shi, JP has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-02-01

US20180030146A1

Chemistry; metallurgy

Human CDR-grafted antibody and antibody fragment thereof

#2 | 2015-11-05

US20150315285A1

Chemistry; metallurgy

Human CDR-grafted antibody and antibody fragment thereof

#3 | 2014-07-03

US20140186349A1

Chemistry; metallurgy

Human CDR-grafted antibody and antibody fragment thereof

#4 | 2012-07-12

US20120177643A1

Human necessities

HUMAN CDR-GRAFTED ANTIBODY AND ANTIBODY FRAGMENT THEREOF

#5 | 2011-03-10

US20110059524A1

Human necessities

Human CDR-grafted antibody and antibody fragment thereof

#6 | 2011-01-13

US20110009600A1

Chemistry; metallurgy

Recombinant antibody composition

#7 | 2010-09-02

US20100221178A1

Physics

Method for treating the Th2-mediated disease

#8 | 2010-04-15

US20100092997A1

Chemistry; metallurgy

Method of enhancing of binding activity of antibody composition to Fcγ receptor IIIa

#9 | 2009-09-10

US20090227012A1

Human necessities

Human CDR-grafted antibody and antibody fragment thereof

#10 | 2005-11-24

US20050260206A1

Chemistry; metallurgy

Drugs containing genetically modified antibody against ganglioside gd3

#11 | 2005-08-25

US20050187380A1

Physics

Method for treating Th2-mediated disease

InventorID:

823398 ⎘